Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia

The human serotonin transporter gene (5-HTT) demonstrates two polymorphisms with possible functional impact: a 44-bp insertion/deletion polymorphism of the promoter region and a 17-bp variable number of tandem repeat polymorphism (VNTR) in intron 2 (STin2). Such genetic polymorphisms in the serotoninergic system may increase the susceptibility to schizophrenia or may serve as predictors of therapeutic response. We therefore analyzed these polymorphisms as susceptibility factors for schizophrenia by comparison of 684 schizophrenic inpatients with 587 healthy controls. We furthermore compared the therapeutic outcome of schizophrenic patients differentiated by the 5-HTT genotypes. Schizo-affective patients were more frequently homozygous for the 44-bp insertion allele (Odds ratio, OR: 1.6, 95% confidence interval, CI: 1.1–2.3, P < 0.03) than were all other schizophrenic patients and controls. The 17-bp VNTR alleles found were: STin2.7, 9, 10, and 12. Sequence analysis revealed seven different sequence motifs with an invariable arrangement. Patients with schizo-paranoid schizophrenia were more frequently homozygous for the STin2.12 allele than were controls (OR: 1.4, CI: 1.1–1.8, P < 0.007) and all other schizophrenic patients (OR: 1.6, CI: 1.2–2.3). The STin2.9 allele represented a risk factor for the residual subtype of schizophrenia (OR: 6.4, CI: 2.5–16.2, P < 0.001). On the basis of global clinical impressions, as well as measurements with the positive and negative syndrome scale we found no association of the polymorphisms with therapeutic response. In conclusion, the 44-bp polymorphism may be associated with the schizo-affective and the 17-bp VNTR with the residual and schizo-paranoid subtype of schizophrenia, findings which require further biochemical and epidemiological confirmation.

[1]  M. Leboyer,et al.  Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression , 1998, Neuroscience Letters.

[2]  J. Quinn,et al.  A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[3]  B. Sokolov,et al.  Abnormal expression of serotonin transporter mRNA in the frontal and temporal cortex of schizophrenics , 1997, Molecular Psychiatry.

[4]  R. Weizman,et al.  A novel allele in the promoter region of the human serotonin transporter gene , 1999, Molecular Psychiatry.

[5]  J. Mallet,et al.  Serotonin transporter gene polymorphism and schizophrenia: An association study , 1997, Biological Psychiatry.

[6]  S. Delbrück,et al.  A novel allelic variant of the human serotonin transporter gene regulatory polymorphism. , 1997, Cytogenetics and cell genetics.

[7]  G. Goodwin,et al.  Polymorphism in serotonin transporter gene associated with susceptibility to major depression , 1996, The Lancet.

[8]  A. Malhotra,et al.  A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics , 1998, Molecular Psychiatry.

[9]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[10]  N. Craddock,et al.  Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT) , 1997, Molecular Psychiatry.

[11]  M. Rietschel,et al.  Serotonin transporter gene and schizophrenia: evidence for association/linkage disequilibrium in families with affected siblings , 2000, Molecular Psychiatry.

[12]  K. Lesch,et al.  Susceptibility for schizophrenia is not influenced by a functional insertion/deletion variant in the promoter of the serotonin transporter gene , 1998, European Archives of Psychiatry and Clinical Neuroscience.

[13]  D. Murphy,et al.  Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. , 1999, American journal of medical genetics.

[14]  K. Lesch,et al.  Serotonin transporter gene polymorphism and affective disorder , 1996, The Lancet.

[15]  R. Blakely,et al.  Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[17]  R. Murray,et al.  The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. , 1996, Neuroreport.

[18]  P Riederer,et al.  Allelic Variation of Human Serotonin Transporter Gene Expression , 1996, Journal of neurochemistry.

[19]  K K Kidd,et al.  A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. , 1993, Human molecular genetics.

[20]  M. Relling,et al.  Pharmacogenomics: translating functional genomics into rational therapeutics. , 1999, Science.

[21]  S. Nanko,et al.  Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder , 1997, Molecular Psychiatry.

[22]  W. Rutter,et al.  The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription , 1995, Nature Genetics.

[23]  G. Goodwin,et al.  Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder , 1996, Psychiatric genetics.

[24]  H. Tanabe,et al.  The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants , 2000, Molecular Psychiatry.

[25]  R. Murray,et al.  A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. , 1996, Molecular psychiatry.